KTTA

Pasithea Therapeutics Corp.

HealthcareBiotechnologyUSUSDPeers →

$0.50

LiveJun 18, 2026

Market cap

$3.72M

52w range

0.28 – 2.06

P / E

—

EPS

—

Volume

196.34K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Pasithea Therapeutics Corp.’s valuation

Enterprise value

-$46.68M

Market cap

$3.72M

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-20

Market capitalisation$3.72M

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value-$46.68M

Valuation

· key metrics · TTM

EV / EBITDA2.2×

EV / Sales0.0×

EV / FCF2.8×

Net debt / EBITDA2.4×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage